In this backdrop, it is important to reflect on India's standing in the fight against HIV/AIDS, given it bears the third-highest burden worldwide. While new infections in the country dropped last year by 19%, they still accounted for 38% of the total in the entire Asia-Pacific region. This is not to say that the country has not been able to mount an effective campaign. New infections, as per the National AIDS Control Organisation, have come down by 57% between 2000 and 2011. But, as the regional figures for new infections show, it is paramount that the country steps up its efforts to spread awareness about transmission wider and to greater effect. Another, perhaps more important, concern is that ART reaches only 36% of the PLHA eligible for it in India. A little over half the people who died on AIDS-related conditions in 2013 in the Asia-Pacific region were Indians. Thus a lot more needs to be done to expand ART outreach. More so, given how the 2012 report of UNAIDS commended India's AIDS response, noting that 80% of the ART drugs worldwide were generics developed in India, saving billions of dollars and easing the fight for low-income nations.